ADCT vs MOS · rev $70.8M vs P/E 161, rev $11.12B
ADC Therapeutics SA (ADCT) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported ADCT revenue for 2024-12-31 was $70.8M. Net income was -$157.8M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. ADCT currently screens at market cap $141.2M.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
ADCT currently screens at market cap $141.2M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the ADCT and MOS stock pages for the full models.
Not investment advice.